Hill-Rom Holdings, Inc. (NYSE:HRC)’s share price hit a new 52-week high on Tuesday . The company traded as high as $85.62 and last traded at $84.26, with a volume of 504800 shares. The stock had previously closed at $83.25.

A number of equities analysts recently weighed in on the stock. Zacks Investment Research raised shares of Hill-Rom from a “sell” rating to a “hold” rating in a research note on Tuesday, September 26th. KeyCorp reaffirmed a “buy” rating and issued a $82.00 target price on shares of Hill-Rom in a research note on Tuesday, October 17th. ValuEngine lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Stifel Nicolaus reaffirmed a “buy” rating and issued a $92.00 target price on shares of Hill-Rom in a research note on Wednesday, November 29th. Finally, Bank of America reaffirmed a “hold” rating on shares of Hill-Rom in a research note on Wednesday, November 22nd. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Hill-Rom has a consensus rating of “Buy” and a consensus price target of $89.57.

The company has a debt-to-equity ratio of 1.55, a current ratio of 1.77 and a quick ratio of 1.34. The firm has a market capitalization of $5,618.48, a P/E ratio of 22.11, a P/E/G ratio of 1.81 and a beta of 1.19.

Hill-Rom (NYSE:HRC) last posted its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.05. Hill-Rom had a net margin of 4.87% and a return on equity of 20.27%. The company had revenue of $738.30 million during the quarter, compared to the consensus estimate of $731.10 million. During the same period in the prior year, the business posted $1.18 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. equities analysts anticipate that Hill-Rom Holdings, Inc. will post 4.26 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.84%. Hill-Rom’s dividend payout ratio is 36.18%.

In other news, SVP Paul Sherwood Johnson sold 1,000 shares of the company’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $82.99, for a total value of $82,990.00. Following the sale, the senior vice president now directly owns 1,066 shares of the company’s stock, valued at approximately $88,467.34. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO John J. Greisch sold 125,241 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $82.59, for a total transaction of $10,343,654.19. Following the completion of the sale, the chief executive officer now directly owns 280,851 shares in the company, valued at $23,195,484.09. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 226,241 shares of company stock valued at $18,708,644. Company insiders own 2.20% of the company’s stock.

Hedge funds have recently modified their holdings of the company. State Street Corp raised its holdings in shares of Hill-Rom by 2.7% in the 2nd quarter. State Street Corp now owns 1,681,107 shares of the medical technology company’s stock valued at $133,831,000 after purchasing an additional 43,645 shares during the period. Principal Financial Group Inc. raised its holdings in Hill-Rom by 8.5% in the 3rd quarter. Principal Financial Group Inc. now owns 283,290 shares of the medical technology company’s stock valued at $20,963,000 after acquiring an additional 22,188 shares during the period. Amalgamated Bank raised its holdings in Hill-Rom by 25.7% in the 2nd quarter. Amalgamated Bank now owns 13,108 shares of the medical technology company’s stock valued at $1,044,000 after acquiring an additional 2,678 shares during the period. Canada Pension Plan Investment Board raised its holdings in Hill-Rom by 42.7% in the 2nd quarter. Canada Pension Plan Investment Board now owns 16,700 shares of the medical technology company’s stock valued at $1,329,000 after acquiring an additional 5,000 shares during the period. Finally, American Century Companies Inc. raised its holdings in Hill-Rom by 1,191.1% in the 2nd quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after acquiring an additional 101,811 shares during the period. 82.33% of the stock is currently owned by institutional investors.

WARNING: “Hill-Rom (HRC) Hits New 52-Week High at $85.62” was published by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.watchlistnews.com/hill-rom-hrc-hits-new-52-week-high-at-85-62/1775951.html.

About Hill-Rom

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.